Notice of Amendments to the Articles of Incorporation | June 24, 2026

Overview of Amendments to the Articles of Incorporation

Asuka Pharmaceutical will propose at the shareholders' meeting on June 24, 2026, the inclusion of their management philosophy in the Articles of Incorporation and the transition to a Company with Audit & Supervisory Committee. This positioning of management philosophy as the core of long-term value creation is intended to improve transparency and facilitate quicker decision-making. The revision of the Articles of Incorporation includes the establishment of the Audit & Supervisory Committee and procedural amendments for directors, with plans to review the officer structure and standards. After the transition, preparations for regulations will proceed to switch from a statutory audit committee to a Company with Audit & Supervisory Committee.

Future Schedule and Impact

Upon approval by shareholders, the amendments to the Articles of Incorporation are expected to become effective on June 24, 2026. This is anticipated to improve management transparency and speed up decision-making, strengthening corporate governance. Changes in Directors and revisions of regulations will further enhance the company's governance structure. For shareholders and stakeholders, this will contribute to the stability of the company's management foundation and long-term growth.